Sohrabi S, Alipour S, Ghahramanipour Z, Masoumi J, Baradaran B
Bioimpacts. 2025; 15:30030.
PMID: 39963570
PMC: 11830145.
DOI: 10.34172/bi.30030.
Shan Q, Qiu J, Dong Z, Xu X, Zhang S, Ma J
Adv Sci (Weinh). 2024; 11(45):e2405490.
PMID: 39401416
PMC: 11615829.
DOI: 10.1002/advs.202405490.
Alakhras N, Zhang W, Barros N, Sharma A, Ropa J, Priya R
Proc Natl Acad Sci U S A. 2024; 121(32):e2400153121.
PMID: 39088391
PMC: 11317592.
DOI: 10.1073/pnas.2400153121.
Yoon J, Bae E, Nagafuchi Y, Sudo K, Han J, Park S
Life Sci Alliance. 2024; 7(9).
PMID: 38960622
PMC: 11222659.
DOI: 10.26508/lsa.201900581.
Li J, Zhang M, Zhang Z, Pan X, Pan L, Sun J
Acta Pharmacol Sin. 2024; 45(7):1466-1476.
PMID: 38514862
PMC: 11192896.
DOI: 10.1038/s41401-024-01242-7.
Leukemic mutation FLT3-ITD is retained in dendritic cells and disrupts their homeostasis leading to expanded Th17 frequency.
Flynn P, Long M, Kosaka Y, Long N, Mulkey J, Coy J
Front Immunol. 2024; 15:1297338.
PMID: 38495876
PMC: 10943691.
DOI: 10.3389/fimmu.2024.1297338.
STAT3 protects hematopoietic stem cells by preventing activation of a deleterious autocrine type-I interferon response.
Patel B, Zhou Y, Babcock R, Ma F, Zal M, Kumar D
Leukemia. 2024; 38(5):1143-1155.
PMID: 38467768
PMC: 11283865.
DOI: 10.1038/s41375-024-02218-6.
Elucidation of molecular basis of osteolytic bone lesions in advanced multiple myeloma.
Shin D, Kim M, Chun S, Kim D, Lee C, Ahn K
Haematologica. 2024; 109(7):2207-2218.
PMID: 38205555
PMC: 11215386.
DOI: 10.3324/haematol.2023.283784.
Identification and validation of the association of Janus kinase 2 mutations with the response to immune checkpoint inhibitor therapy.
Chen P, Long J, Zhang J, Xie F, Wu W, Tian Z
Inflamm Res. 2024; 73(2):263-276.
PMID: 38200372
PMC: 10824873.
DOI: 10.1007/s00011-023-01833-w.
An Overview of the Immune Modulatory Properties of Long Non-Coding RNAs and Their Potential Use as Therapeutic Targets in Cancer.
Martinez-Castillo M, Elsayed A, Lopez-Berestein G, Amero P, Rodriguez-Aguayo C
Noncoding RNA. 2023; 9(6).
PMID: 37987366
PMC: 10660772.
DOI: 10.3390/ncrna9060070.
Defective Induction of IL-27-Mediated Immunoregulation by Myeloid DCs in Multiple Sclerosis.
von Glehn F, Pochet N, Thapa B, Raheja R, Mazzola M, Jangi S
Int J Mol Sci. 2023; 24(9).
PMID: 37175706
PMC: 10179146.
DOI: 10.3390/ijms24098000.
JAK/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens.
Hu Q, Bian Q, Rong D, Wang L, Song J, Huang H
Front Bioeng Biotechnol. 2023; 11:1110765.
PMID: 36911202
PMC: 9995824.
DOI: 10.3389/fbioe.2023.1110765.
STAT3 protects HSCs from intrinsic interferon signaling and loss of long-term blood-forming activity.
Patel B, Zhou Y, Babcock R, Ma F, Zal M, Kumar D
bioRxiv. 2023; .
PMID: 36798265
PMC: 9934695.
DOI: 10.1101/2023.02.10.528069.
STAT3 signaling modulates the immune response induced after antigen targeting to conventional type 1 dendritic cells through the DEC205 receptor.
Sulczewski F, Martino L, Salles D, Yamamoto M, Santoro Rosa D, Boscardin S
Front Immunol. 2022; 13:1006996.
PMID: 36330518
PMC: 9624190.
DOI: 10.3389/fimmu.2022.1006996.
The Toxoplasma effector GRA28 promotes parasite dissemination by inducing dendritic cell-like migratory properties in infected macrophages.
Ten Hoeve A, Braun L, Rodriguez M, Olivera G, Bougdour A, Belmudes L
Cell Host Microbe. 2022; 30(11):1570-1588.e7.
PMID: 36309013
PMC: 9710525.
DOI: 10.1016/j.chom.2022.10.001.
Identification of hub genes related to the innate immune response activated during spinal cord injury.
Li J, Liu X, Wu H, Guo P, Li B, Wang J
FEBS Open Bio. 2022; 12(10):1839-1856.
PMID: 36047918
PMC: 9527585.
DOI: 10.1002/2211-5463.13472.
Meta-Analysis of Two Human RNA-seq Datasets to Determine Periodontitis Diagnostic Biomarkers and Drug Target Candidates.
Moreno C, Bybee E, Tellez Freitas C, Pickett B, Weber K
Int J Mol Sci. 2022; 23(10).
PMID: 35628390
PMC: 9145972.
DOI: 10.3390/ijms23105580.
STAT6 signaling pathway controls germinal center responses promoted after antigen targeting to conventional type 2 dendritic cells.
Sulczewski F, Martino L, Almeida B, Yamamoto M, Santoro Rosa D, Boscardin S
Curr Res Immunol. 2022; 2:120-131.
PMID: 35492396
PMC: 9040147.
DOI: 10.1016/j.crimmu.2021.08.001.
Cell Type-Specific Roles of STAT3 Signaling in the Pathogenesis and Progression of K-ras Mutant Lung Adenocarcinoma.
Clowers M, Moghaddam S
Cancers (Basel). 2022; 14(7).
PMID: 35406557
PMC: 8997152.
DOI: 10.3390/cancers14071785.
STAT3 pathway in cancers: Past, present, and future.
Wang H, Man Q, Huo F, Gao X, Lin H, Li S
MedComm (2020). 2022; 3(2):e124.
PMID: 35356799
PMC: 8942302.
DOI: 10.1002/mco2.124.